ETFOptimize | High-performance ETF-based Investment Strategies

Quantitative strategies, Wall Street-caliber research, and insightful market analysis since 1998.


ETFOptimize | HOME
Close Window

Korean Stem Cell Therapy For Shoulder Arthritis: Medical Tourism Service Expands

Lydian Cosmetic Surgery Clinic in Seoul is expanding its stem cell therapy treatments for shoulder arthritis for international patients. The clinic's Class 10,000 clean environment and advanced techniques position it as an attractive regenerative medicine destination for global medical tourists.

-- The recent expansion from Lydian Cosmetic Surgery Clinic addresses a gap in international medicine for those with shoulder arthritis pain who face prohibitive treatment expenses in their home countries. Offered with bilingual care for international patients, Lydian Cosmetic Surgery Clinic's mesenchymal stem cell therapy treatments help to reduce pain, regenerate tissue, and improve mobility of the shoulder.

Interested parties can learn more at https://www.lydianclinic.com/blog/korean-stem-cell-therapy-cost-shoulder-arthritis

Financial barriers remain a primary obstacle for patients with degenerative joint conditions. In 2025, 25% of patients surveyed paid more than $20,000 for a single stem cell therapy treatment, according to reporting from The Niche, run by experts at the University of California Davis School of Medicine. These high costs often force reliance on pain management or premature surgical intervention.

However, similar treatments in Korea typically cost 40 to 65% less, making the country an attractive medical tourism destination for patients from Southeast Asia, the Middle East, Europe, and North America. In response to this need, Lydian Cosmetic Surgery Clinic provides bilingual coordinators and medical tourism logistics support for non-Korean speakers.

Using ultrasound guidance, the Lydian Clinic injects mesenchymal stem cells derived from the patient's own adipose tissue or bone marrow, processed in laboratories that comply with international safety standards, directly into the shoulder. These cells work to repair damaged cartilage, reduce inflammation, improve range of motion, and alleviate chronic pain by addressing underlying tissue degeneration rather than masking symptoms.

The team explains that most individuals who receive stem cell therapy at the Lydian Clinic can return to daily activities within one to three days and can fly home within three to five days post-treatment, experiencing only mild soreness or swelling that resolves within 48 to 72 hours. Patients may notice initial improvements within three to six weeks, though the timeline varies depending upon individual factors and condition severity. Continued tissue regeneration occurs over 12 months.

Potential stem cell therapy candidates at the Lydian Clinic include those with mild-to-moderate shoulder arthritis, rotator cuff degeneration, or chronic pain unresponsive to physical therapy who wish to preserve joint function and delay or avoid surgery. Candidacy is determined through a free personalized consultation with qualified specialists, as the treatment is not appropriate for severe arthritis requiring joint replacement.

For more information, please visit https://www.lydianclinic.com/stemcelleng

Contact Info:
Name: Dr. Abraham An
Email: Send Email
Organization: Lydian Cosmetic Surgery Clinic
Address: 836 Nonhyeon-ro, Sinsa-dong, Gangnam, Seoul, Seoul 06025, Korea, Republic of
Website: https://www.lydianclinic.com/

Source: NewsNetwork

Release ID: 89178568

If there are any errors, inconsistencies, or queries arising from the content contained within this press release that require attention or if you need assistance with a press release takedown, we kindly request that you inform us immediately by contacting error@releasecontact.com (it is important to note that this email is the authorized channel for such matters, sending multiple emails to multiple addresses does not necessarily help expedite your request). Our reliable team will be available to promptly respond within 8 hours, taking proactive measures to rectify any identified issues or providing guidance on the removal process. Ensuring accurate and dependable information is our top priority.

Recent Quotes

View More
Symbol Price Change (%)
AMZN  232.14
+3.71 (1.62%)
AAPL  272.36
+1.39 (0.51%)
AMD  214.90
-0.05 (-0.02%)
BAC  55.97
+0.09 (0.16%)
GOOG  315.68
+4.35 (1.40%)
META  664.94
+3.44 (0.52%)
MSFT  486.85
+1.93 (0.40%)
NVDA  189.21
+5.52 (3.01%)
ORCL  195.34
-3.04 (-1.53%)
TSLA  485.56
-3.17 (-0.65%)
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.


 

IntelligentValue Home
Close Window

DISCLAIMER

All content herein is issued solely for informational purposes and is not to be construed as an offer to sell or the solicitation of an offer to buy, nor should it be interpreted as a recommendation to buy, hold or sell (short or otherwise) any security.  All opinions, analyses, and information included herein are based on sources believed to be reliable, but no representation or warranty of any kind, expressed or implied, is made including but not limited to any representation or warranty concerning accuracy, completeness, correctness, timeliness or appropriateness. We undertake no obligation to update such opinions, analysis or information. You should independently verify all information contained on this website. Some information is based on analysis of past performance or hypothetical performance results, which have inherent limitations. We make no representation that any particular equity or strategy will or is likely to achieve profits or losses similar to those shown. Shareholders, employees, writers, contractors, and affiliates associated with ETFOptimize.com may have ownership positions in the securities that are mentioned. If you are not sure if ETFs, algorithmic investing, or a particular investment is right for you, you are urged to consult with a Registered Investment Advisor (RIA). Neither this website nor anyone associated with producing its content are Registered Investment Advisors, and no attempt is made herein to substitute for personalized, professional investment advice. Neither ETFOptimize.com, Global Alpha Investments, Inc., nor its employees, service providers, associates, or affiliates are responsible for any investment losses you may incur as a result of using the information provided herein. Remember that past investment returns may not be indicative of future returns.

Copyright © 1998-2017 ETFOptimize.com, a publication of Optimized Investments, Inc. All rights reserved.